Daily Direct Active Monitoring Tracking Report - email

Emergency Submission for Active Monitoring of Travelers Coming from Ebola-affected Countries and Their Contacts Currently Residing in State, Territorial, and Local Jurisdictions

AttC1 - Daily Direct Active Monitoring email Template

Daily Direct Active Monitoring Tracking Report - email

OMB: 0920-1066

Document [docx]
Download: docx | pdf

Attachment C1 - Daily Direct Active Monitoring email Template

Directions to respondent:

Please report the following information for each traveler in your email:

Traveler information

City

 

State

 

State assigned ID

 

CDC Id / Traveler's Health ID

 

CDC Risk Category (High, Some)

 

Healthcare Worker (y/n)

 

Citizenship Status (if not U.S. Citizen)

 

Arrival in Jurisdiction Date

 

U.S. Entry Airport

 

If other

 

U.S. Entry Date

 

Hospital Identified (y/n)

 

Local Hospital

 

Transport Plan to Hospital (y/n)

 

Travelling During Monitoring Period (y/n)

 

Summary of travel plans

 

Comments

 

Daily Monitoring

Date of Last Some or High Risk Exposure

 

Today's Date

 

Contacted?

 

Reason for No Contact

 

Symptom (y/n)

 

Description of Symptoms

 

Referred for Evaluation (y/n)

 

Referred for testing?(y/n)

 

Comments

 

Shape1

Public reporting burden of this collection of information is estimated to average 4 minutes per response including the time for reviewing instructions, searching existing data sources gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ASTDR Information Collection Review Office, 1600 Clifton Rd NE, MS-D74, Atlanta, Georgia 30333: ATTN:PRA (0920-xxxx)











Dictionary

Variable Name

Variable Description

Response

State assigned ID

A unique ID for the traveler, ascribed by the state conducting the direct active monitoring (DAM), should stay the same throughout the DAM reporting period (typically 21 days)

text

Traveler Health Declaration ID

A unique ID for the traveler, ascribed by CDC when form is received from CBP; should stay the same throughout the DAM reporting period (typically 21 days)

text

State

State that is conducting the DAM and reporting

text

CDC Risk Category (High, Some, Low)

Risk category according to CDC's Interim Guidance for the Monitoring and Movement of persons with potential exposure to ebola virus disease*

some or high*

HCW

Was the traveler a healthcare worker treating patients in W. Africa

y/n

Hospital Identified

Has a hospital been identified that the travel will be taken to if he or she becomes symptomatic?

y/n

Hospital Name

Name of hospital identified that the traveler will be taken to if he or she becomes symptomatic

text

Transfer Plan

Is a transfer plan in place for moving the traveler to the hospital if he or she becomes symptomatic

y/n

Travel Plans

Does the person have travel plans during the monitoring period

yes/no

Travel Plans

Summary of person's plans for travel within the monitoring period and jurisdiction's plans for continued monitoring

text

Date of person's last exposure

Date person was last exposed to the event that put them in the some or high category

Date

Date of entry into the US

Date person was last exposed to the event that put them in the some or high category

Date

Days until DAM completed

Number of days until the 21 day incubation period is over (=Today's date -Date of last exposure)

Number (0-21)

Date 21 days post-exposure

Date the 21 day incubation period should end (=exposure +21)

Date

Date of last DAM (as of midnight) 1

Day for which this report reflects (normally yesterday)

Date

If no, why (Txt)

If not, why not; could reflect "DAM Period Completed"

text

Total Number of Days DAM was required

Total number of days that DAM was required; will usually be (= Today - Date of Entry to U.S) but might defer for unique situations (DAM officially began 10/27/14)

Number

Number of Days until DAM is completed

Total number of days until DAM period is completed (# of days required minus number of days completed or missed)

Number

Total Number of Days DAM completed

Total number of days that DAM was completed successfully (based on "y" on tracking worksheet)

Number

Total Number of Days DAM missed

Total number of days that DAM was missed (based on "n" on tracking worksheet)

Number

% of days completed

Percentage of number of days DAM completed within the required period

Percent

Symptom (y/n)

Did traveler have fever or other symptom such as severe headache, muscle pain, vomitting, diarrhea, stomach pain, unexplained bruising or bleeding

yes/no

Refered for Evaluation (y/n)

Was the person referred for medical evaluation?

yes/no

Refered for testing (y/n)

Was the person referred for testing for EVD?

yes/no




High risk includes any of the following:



Percutaneous (e.g., needle stick) or mucous membrane exposure to blood or body fluids of a person with Ebola while the person was symptomatic


Exposure to the blood or body fluids (including but not limited to feces, saliva, sweat, urine, vomit, and semen) of a person with Ebola while the person was symptomatic without appropriate personal protective equipment (PPE)(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html)


Processing blood or body fluids of a person with Ebola while the person was symptomatic without appropriate PPE(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html) or standard biosafety precautions


Direct contact with a dead body without appropriate PPE(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html) in a country with widespread Ebola virus transmission(http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/distribution-map.html)


Having lived in the immediate household and provided direct care to a person with Ebola while the person was symptomatic




Some risk includes any of the following:



In countries with widespread Ebola virus transmission(http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/distribution-map.html): direct contact while using appropriate PPE(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html) with a person with Ebola while the person was symptomatic


Close contact in households, healthcare facilities, or community settings with a person with Ebola while the person was symptomatic


Close contact is defined as being for a prolonged period of time while not wearing appropriate PPE(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html) within approximately 3 feet (1 meter) of a person with Ebola while the person was symptomatic










File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created2021-01-25

© 2024 OMB.report | Privacy Policy